Breast Cancer Patient Treatment Journey Study
A quantitative research study exploring breast cancer treatment strategies, patient journeys, treatment gaps, and unmet medical needs for HR+/HER2- and triple-negative breast cancer. The study gathered perspectives from oncology specialists across six European markets to support treatment and product strategy.